STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – HCCI, CEQP, CELL, CTG
September 05, 2023 19:34 ET
|
Monteverde & Associates PC
NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Cast Acrylic Market revenue to reach USD 5 Billion by 2035, says Research Nester
September 05, 2023 07:30 ET
|
Research Nester
New York, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The global cast acrylic market size is poised to grow at a CAGR of over ~5% from 2023 to 2035. The market is anticipated to garner a revenue of USD 5...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DBTX, CELL, ESTE, CPRI
August 28, 2023 17:34 ET
|
Monteverde & Associates PC
NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – CELL, DBTX, CPRI, ESTE
August 21, 2023 17:32 ET
|
Monteverde & Associates PC
NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Arch Biopartners Receives Permission From U.S. FDA to Proceed With Phase II Acute Kidney Injury Trial
June 27, 2023 07:15 ET
|
Arch Biopartners
Approval from FDA to initiate Phase II trial with LSALT peptide to target cardiac surgery-associated acute kidney injury (CS-AKI)LSALT peptide targets dipeptidase-1 (DPEP-1), an enzyme known to...
Precipio Ships First IV-Cell® Order to Major US Healthcare System
March 21, 2023 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) delivered its first order of IV-Cell®, the Company’s proprietary cytogenetics...
Regenerative Medicine Market Growth Report ($37.48 Billion) Lead by Increasing Adoption of Gene Therapies | The Insight Partners
February 09, 2023 09:08 ET
|
The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Regenerative Medicine Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
Cell-Counting Devices Market Size is projected to reach USD 28.45 billion by 2029, with growth at a CAGR of 7.21% over the forecast period 2022-2029
November 23, 2022 10:00 ET
|
DataM Intelligence
ENTERPRISE, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Cell-Counting Devices Market Size Growth Rate Overview: According to the research report published by DataM Intelligence, the global cell...
Cell Therapy Market Size Worth USD 26.9 Billion by 2030 at 9.3% CAGR - Report by Market Research Future (MRFR)
August 23, 2022 12:00 ET
|
Market Research Future
New York, USA, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Cell Therapy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), "Cell Therapy...
Glycomics Market is projected to reach US$ 3,223.30 million by 2028 at 13.4% CAGR - Exclusive Report by The Insight Partners
July 18, 2022 08:30 ET
|
The Insight Partners
New York, July 18, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Glycomics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product,...